# Study of GA-GCB Enzyme Replacement Therapy in Type 1 Gaucher Disease Patients Previously Treated With Imiglucerase

> **NCT00478647** · PHASE2,PHASE3 · COMPLETED · sponsor: **Shire** · enrollment: 40 (actual)

## Conditions studied

- Gaucher Disease

## Interventions

- **BIOLOGICAL:** GA-GCB (velaglucerase alfa)

## Key facts

- **NCT ID:** NCT00478647
- **Lead sponsor:** Shire
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-07-25
- **Primary completion:** 2009-06-26
- **Final completion:** 2009-06-26
- **Target enrollment:** 40 (ACTUAL)
- **Last updated:** 2021-06-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00478647

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00478647, "Study of GA-GCB Enzyme Replacement Therapy in Type 1 Gaucher Disease Patients Previously Treated With Imiglucerase". Retrieved via AI Analytics 2026-07-19 from https://api.ai-analytics.org/clinical/NCT00478647. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*